Logo image of HRC

Hill Rom Holdings (HRC) Stock Fundamental Analysis

NYSE:HRC - New York Stock Exchange, Inc. - Common Stock

155.96  +0.05 (+0.03%)

After market: 155.96 0 (0%)

Fundamental Rating

2

Taking everything into account, HRC scores 2 out of 10 in our fundamental rating. HRC was compared to 188 industry peers in the Health Care Equipment & Supplies industry. HRC has a bad profitability rating. Also its financial health evaluation is rather negative. HRC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HRC had positive earnings in the past year.
HRC Yearly Net Income VS EBIT VS OCF VS FCFHRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M 500M

1.2 Ratios

Industry RankSector Rank
ROA 4.97%
ROE 13.22%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HRC Yearly ROA, ROE, ROICHRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 5 10 15

1.3 Margins

Industry RankSector Rank
OM 17.4%
PM (TTM) 8.23%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HRC Yearly Profit, Operating, Gross MarginsHRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30 40 50

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for HRC has been reduced compared to 1 year ago.
HRC has a worse debt/assets ratio than last year.
HRC Yearly Shares OutstandingHRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M
HRC Yearly Total Debt VS Total AssetsHRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.60 indicates that HRC is not in any danger for bankruptcy at the moment.
HRC has a Debt/Equity ratio of 0.97. This is a neutral value indicating HRC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 3.6
ROIC/WACCN/A
WACCN/A
HRC Yearly LT Debt VS Equity VS FCFHRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

2.3 Liquidity

HRC has a Current Ratio of 1.38. This is a normal value and indicates that HRC is financially healthy and should not expect problems in meeting its short term obligations.
HRC has a Quick Ratio of 1.05. This is a normal value and indicates that HRC is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.05
HRC Yearly Current Assets VS Current LiabilitesHRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

More info and screens

5

3. Growth

3.1 Past

HRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.10%, which is quite good.
Measured over the past years, HRC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.30% on average per year.
Looking at the last year, HRC shows a small growth in Revenue. The Revenue has grown by 4.78% in the last year.
HRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.60% yearly.
EPS 1Y (TTM)14.1%
EPS 3Y9.93%
EPS 5Y13.3%
EPS Q2Q%42.74%
Revenue 1Y (TTM)4.78%
Revenue growth 3Y1.96%
Revenue growth 5Y2.6%
Sales Q2Q%13.13%

3.2 Future

Based on estimates for the next years, HRC will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.11% on average per year.
The Revenue is expected to grow by 5.87% on average over the next years.
EPS Next Y3.85%
EPS Next 2Y7.49%
EPS Next 3Y9.22%
EPS Next 5Y10.11%
Revenue Next Year3.75%
Revenue Next 2Y4.37%
Revenue Next 3Y5.68%
Revenue Next 5Y5.87%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HRC Yearly Revenue VS EstimatesHRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
HRC Yearly EPS VS EstimatesHRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.72, the valuation of HRC can be described as rather expensive.
The average S&P500 Price/Earnings ratio is at 26.55. HRC is around the same levels.
A Price/Forward Earnings ratio of 23.80 indicates a rather expensive valuation of HRC.
HRC is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.72
Fwd PE 23.8
HRC Price Earnings VS Forward Price EarningsHRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.16
HRC Per share dataHRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)6.41
PEG (5Y)1.86
EPS Next 2Y7.49%
EPS Next 3Y9.22%

More info and screens

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.62%, HRC is not a good candidate for dividend investing.
With a Dividend Yield of 0.62, HRC pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.62%

5.2 History

The dividend of HRC is nicely growing with an annual growth rate of 6.42%!
HRC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr YearsN/A
Div Non Decr YearsN/A
HRC Yearly Dividends per shareHRC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6 0.8

5.3 Sustainability

HRC pays out 24.95% of its income as dividend. This is a sustainable payout ratio.
HRC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP24.95%
EPS Next 2Y7.49%
EPS Next 3Y9.22%
HRC Yearly Income VS Free CF VS DividendHRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
HRC Dividend Payout.HRC Dividend Payout, showing the Payout Ratio.HRC Dividend Payout.PayoutRetained Earnings

More info and screens

Hill Rom Holdings

NYSE:HRC (12/10/2021, 8:15:43 PM)

After market: 155.96 0 (0%)

155.96

+0.05 (+0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)02-15 2022-02-15/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners0.66%
Ins Owner Change0%
Market Cap10.42B
Analysts51.43
Price Target159.12 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.62%
Yearly Dividend0.94
Dividend Growth(5Y)6.42%
DP24.95%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 24.72
Fwd PE 23.8
P/S 3.45
P/FCF N/A
P/OCF N/A
P/B 5.54
P/tB N/A
EV/EBITDA 17.16
EPS(TTM)6.31
EY4.05%
EPS(NY)6.55
Fwd EY4.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS45.2
BVpS28.15
TBVpSN/A
PEG (NY)6.41
PEG (5Y)1.86
Profitability
Industry RankSector Rank
ROA 4.97%
ROE 13.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 17.4%
PM (TTM) 8.23%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 1.05
Altman-Z 3.6
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.1%
EPS 3Y9.93%
EPS 5Y13.3%
EPS Q2Q%42.74%
EPS Next Y3.85%
EPS Next 2Y7.49%
EPS Next 3Y9.22%
EPS Next 5Y10.11%
Revenue 1Y (TTM)4.78%
Revenue growth 3Y1.96%
Revenue growth 5Y2.6%
Sales Q2Q%13.13%
Revenue Next Year3.75%
Revenue Next 2Y4.37%
Revenue Next 3Y5.68%
Revenue Next 5Y5.87%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A